SHOULDER INNOVATIONS, INC. Payments to Acquire Debt Securities, Available-for-sale
SHOULDER INNOVATIONS, INC. (SI) reported Payments to Acquire Debt Securities, Available-for-sale of $18.17 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-08-06
- SHOULDER INNOVATIONS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- SHOULDER INNOVATIONS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2026-03-31 was $18.17M, a 9.42% decline year-over-year.
- SHOULDER INNOVATIONS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-12-31 was $23.91M, a 2530.25% increase year-over-year.
- SHOULDER INNOVATIONS, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-30 was $75.11M, a 23009.23% increase year-over-year.
- SHOULDER INNOVATIONS, INC. payments to acquire debt securities, available-for-sale for fiscal 2025 was $119.49M, a 2162.66% increase from fiscal 2024.
- SHOULDER INNOVATIONS, INC. payments to acquire debt securities, available-for-sale for fiscal 2024 was $5.28M.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $18.17M 10-Q · filed 2026-08-06 | $42.08M derived: sum of 3 quarters · filed 2026-08-06 | $117.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $18.17M 10-Q · filed 2026-05-13 | $42.08M derived: sum of 2 quarters · filed 2026-05-13 | $117.18M derived: sum of 3 quarters · filed 2026-05-13 | $117.60M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $23.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $99.01M derived: sum of 2 quarters · filed 2026-03-10 | $99.43M derived: sum of 3 quarters · filed 2026-08-06 | $119.49M 10-K · filed 2026-03-10 |
| 2025-09-30 | $75.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $75.52M derived: sum of 2 quarters · filed 2026-08-06 | $95.58M 10-Q · filed 2025-11-12 | $96.49M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $417.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $20.48M 10-Q · filed 2026-08-06 | $21.39M derived: sum of 3 quarters · filed 2026-08-06 | $21.71M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $20.06M 10-Q · filed 2026-05-13 | $20.97M derived: sum of 2 quarters · filed 2026-05-13 | $21.29M derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-31 | $909.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.23M derived: sum of 2 quarters · filed 2026-03-10 | $5.28M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $325.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $4.37M 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $4.05M 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |